SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AB Science Release: European Medicines Agency Accepts Marketing Application for Masitinib in the Treatment of Gleevec® Resistant Gastro-Intestinal Stromal Tumor